We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 161

States Regulating PFAS in Food Packaging: What You Need to Know Now
  • Pepper Hamilton LLP
  • USA
  • April 12 2018

Last month, Washington state enacted a new law, making it the first in the country to ban the use of perfluoroalkyl and polyfluoroalkyl substances, or

Washington Healthcare Update - February 6, 2017
  • McGuireWoods LLP
  • USA
  • February 6 2017

Republican members of the House Energy & Commerce Committee at a Feb. 1 health subcommittee hearing asked witnesses whether state Medicaid programs

Washington Healthcare Update - November 7th, 2016
  • McGuireWoods LLP
  • USA
  • November 7 2016

In a Nov. 3 letter, Reps. Diana DeGette (D-CO) and Susan Brooks (R-ID), both members of the House Energy and Commerce Committee, asked the Food and

Product Liability eNewsletter - Summer 2016
  • Thompson Hine LLP
  • USA, Ireland
  • July 25 2016

The Food and Drug Administration’s (FDA) June 17, 2015 final determination regarding partially hydrogenated oils (PHOs), the primary source of trans

Washington State issues temporary ban on alcoholic energy drinks
  • Shook Hardy & Bacon LLP
  • USA
  • November 12 2010

The Washington State Liquor Control Board (WSLCB) has passed a resolution to temporarily "prevent the further sale and distribution of malt beverage products containing caffeine and other stimulants."

Listeria recall toolkit
  • Stoel Rives LLP
  • USA
  • October 28 2010

The FDA recently took the relatively unusual step of obtaining a court-issued warrant to seize all cheese products at Estrella Family Creamery, a small, family-owned artisan cheese maker in Washington State.

Material omission of negative FDA inspection report supports securities fraud allegations
  • Katten Muchin Rosenman LLP
  • USA
  • December 19 2008

The defendant biotech company submitted an application to the Food and Drug Administration (FDA) to approve one of its drugs.